Committee for Ethics in Clinical Research in La Rioja (CEICLAR)

Atención, se abre en una ventana nueva.
  • Imprimir
  • Basic principles and legal framework

    Clinical trials with well designed and produced drugs are considered the best scientific tools at our disposal to demonstrate the effectiveness and / or safety of a new prophylactic, diagnostic or therapeutic resource. However, it is necessary to conciliate research in human beings with the protection and safeguard of the rights of the subjects of this research. To this end, the scientific community has drawn up a series of documents which, at the time of their drafting, were accepted as recommendations and, subsequently, their principles were taken up and included in regulations with a legal status, whereby compliance therewith is obligatory. Numbering among them are The Nuremberg Code (1947), the Declaration of Helsinki (1964), the Belmont Report (1978), the Oviedo Convention (1997) and the Edinburgh revision of the Declaration of Helsinki (2000) and its subsequent Clarification (2001).

    CEICLARComplying with the need for the Clinical Research Ethics Committee of La Rioja, created by Decree 10/1995, of 2nd March, to adapt itself and be accredited in accordance with the stipulations introduced by the Royal Decree 223/2004, adjusting to the current organizational model of the Health System of La Rioja, the Executive Council of the Government of La Rioja passed Decree 71/2005 of 2nd December, which gave rise to the Clinical Research Ethics Committee of La Rioja (CEICLAR) as it is today.